Jacques Grosset

Research output

Research output per year 1956 1978 1982 1983 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2005 2009 2011 2013 2015 2020

• 365 Article
• 23 Review article
• 19 Letter
• 10 Editorial
• 17 More
  • 8 Comment/debate
  • 4 Chapter
  • 4 Short survey
  • 1 Book

Research output per year

Research output per year

Search results

• 2018

  An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP++

  Mieras, L. F., Taal, A. T., Van Brakel, W. H., Cambau, E., Saunderson, P. R., Smith, W. C. S., Prakoeswa, C. R. S., Astari, L., Scollard, D. M., Do Nascimento, D. C., Grosset, J., Kar, H. K., Izumi, S., Gillini, L., Virmond, M. C. L. & Sturkenboom, M. G. G., Oct 5 2018, In: BMC infectious diseases. 18, 1, 506.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Post-Exposure Prophylaxis 100%
  • Leprosy 79%
  • Chemoprevention 76%
  • Rifampin 26%
  • Moxifloxacin 24%

• Tuberculosis in France before, during, and after World War II

  Grosset, J. & Trébucq, A., 2018, In: Progress in Respiratory Research. 43, p. 116-123 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • World War II 100%
  • France 69%
  • Tuberculosis 60%
  • World War I 46%
  • Concentration Camps 26%
• 2013

  Dose-ranging activity of the newly registered antituberculosis drug bedaquiline (TMC207)

  Grosset, J. H. & Ammerman, N. C., Jul 2013, In: Expert Review of Anti-Infective Therapy. 11, 7, p. 649-651 3 p.

  Research output: Contribution to journal › Review article › peer-review

  • bedaquiline 100%
  • Pharmaceutical Preparations 25%
  • Rifampin 12%
  • Pulmonary Tuberculosis 12%
  • Sputum 12%
  3 Scopus citations
• 2012

  New drugs for the treatment of tuberculosis: Hope and reality

  Grosset, J. H., Singer, T. G. & Bishai, W. R., Aug 1 2012, In: International Journal of Tuberculosis and Lung Disease. 16, 8, p. 1005-1014 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Tuberculosis 100%
  • Ethambutol 93%
  • Pharmaceutical Preparations 50%
  • posizolid 50%
  • PNU-100480 48%
  96 Scopus citations
• 2011

  Treating Mycobacterium ulcerans disease (Buruli ulcer): From surgery to antibiotics, is the pill mightier than the knife?

  Converse, P., Nuermberger, E. L., Almeida, D. V. & Grosset, J. H., Oct 2011, In: Future microbiology. 6, 10, p. 1185-1198 14 p.

  Research output: Contribution to journal › Review article › peer-review

  • Mycobacterium ulcerans 100%
  • Buruli Ulcer 97%
  • Anti-Bacterial Agents 40%
  • Skin Transplantation 38%
  • Streptomycin 36%
  33 Scopus citations

• Treatment of tuberculosis and optimal dosing schedules

  Chang, K. C., Leung, C. C., Grosset, J. & Yew, W. W., Nov 2011, In: Thorax. 66, 11, p. 997-1007 11 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Tuberculosis 100%
  • Appointments and Schedules 98%
  • rifamycin SV 94%
  • Pharmacokinetics 68%
  • Systematic Reviews 67%
  47 Scopus citations
• 2004

  Latent tuberculosis infection

  Nuermberger, E., Bishai, W. R. & Grosset, J. H., Jun 2004, In: Seminars in Respiratory and Critical Care Medicine. 25, 3, p. 317-336 20 p.

  Research output: Contribution to journal › Review article › peer-review

  • Latent Tuberculosis 100%
  • Tuberculosis 63%
  • Host-Pathogen Interactions 25%
  • Tuberculin Test 24%
  • Skin Tests 19%
  32 Scopus citations

• Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections

  Nuermberger, E. & Grosset, J., Apr 2004, In: European Journal of Clinical Microbiology and Infectious Diseases. 23, 4, p. 243-255 13 p.

  Research output: Contribution to journal › Review article › peer-review

  • Pharmacokinetics 100%
  • Infections 63%
  • Mycobacterium 40%
  • Mycobacterium avium Complex 25%
  • Anti-Bacterial Agents 24%
  104 Scopus citations
• 2003

  Fluoroquinolones, tuberculosis, and resistance

  Ginsburg, A. S., Grosset, J. H. & Bishai, W. R., Jul 1 2003, In: Lancet Infectious Diseases. 3, 7, p. 432-442 11 p.

  Research output: Contribution to journal › Review article › peer-review

  • Fluoroquinolones 100%
  • Tuberculosis 73%
  • Mycobacterium tuberculosis 14%
  • Treatment Failure 14%
  • Prescriptions 12%
  334 Scopus citations
• 2000

  Donnees recentes sur la tuberculose

  Translated title of the contribution: Recent data on tuberculosisUffredi, M. L. & Grosset, J., Jan 1 2000, In: Medecine Therapeutique. 6, 6, p. 429-433 5 p.

  Research output: Contribution to journal › Review article › peer-review
  1 Scopus citations

• Infection a Mycobacterium ulcerans

  Translated title of the contribution: Mycobacterium ulcerans infectionDega, H., Chosidow, O., Barete, S., Carbonnelle, B., Grosset, J. & Jarlier, V., Nov 9 2000, In: Annales de Medecine Interne. 151, 5, p. 339-344 6 p.

  Research output: Contribution to journal › Review article › peer-review

  • Mycobacterium ulcerans 100%
  • Buruli Ulcer 97%
  • mycolactone 37%
  • Ulcer 18%
  • Cicatrix 17%
  11 Scopus citations
• 1999

  Drugs and regimens for preventive therapy against tuberculosis, disseminated Mycobacterium avium complex infection and leprosy.

  Ji, B. & Grosset, J. H., Dec 1999, In: International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 67, 4 Suppl, p. S45-55

  Research output: Contribution to journal › Review article › peer-review
  2 Scopus citations

• Pharmacokinetics and animal studies of rifapentine in tuberculosis

  Lounis, N., Truffot-Pernot, C., Ji, B. & Grosset, J., Dec 1 1999, In: Drugs of Today. 35, SUPPL. D, p. 17-27 11 p.

  Research output: Contribution to journal › Review article › peer-review

  • rifapentine 100%
  • Tuberculosis 48%
  • Pharmacokinetics 44%
  • Rifampin 39%
  • Animals 29%
  1 Scopus citations
• 1997

  Advances in tuberculosis preventive therapy

  Grosset, J. H. & O'Brien, R. J., Jan 1 1997, In: Seminars in Respiratory and Critical Care Medicine. 18, 5, p. 449-457 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Isoniazid 100%
  • Tuberculosis 82%
  • Tuberculin 44%
  • HIV 34%
  • rifapentine 21%
  7 Scopus citations

• Bactériologie de la tuberculose et des infections à mycobactéries non tuberculeuses.

  Translated title of the contribution: The bacteriology of tuberculosis and non-tuberculosis mycobacterial infectionsWyplosz, B., Truffot-Pernot, C., Robert, J., Jarlier, V. & Grosset, J., Dec 1997, In: Revue des maladies respiratoires. 14 Suppl 5, p. S33-48

  Research output: Contribution to journal › Review article › peer-review

  • Bacteriology 100%
  • Mycobacterium 82%
  • Tuberculosis 62%
  • Bacillus 37%
  • Infections 36%
  4 Scopus citations

• Prevention of the selection of clarithromycin-resistant Mycobacterium avium-intracellulare complex

  Grosset, J. & Ji, B., 1997, In: Drugs. 54, SUPPL. 2, p. 23-27 5 p.

  Research output: Contribution to journal › Review article › peer-review

  • Mycobacterium avium Complex 100%
  • Clarithromycin 90%
  • Mycobacterium avium-intracellulare Infection 27%
  • CD4 Lymphocyte Count 25%
  • Acquired Immunodeficiency Syndrome 21%
  6 Scopus citations
• 1994

  Les moyens de diagnostic bactériologique de la tuberculose

  Translated title of the contribution: Bacteriology for diagnosis of tuberculosisTruffot-Pernot, C. & Grosset, J., Oct 1994, In: Medecine et Maladies Infectieuses. 24, 10, p. 871-873 3 p.

  Research output: Contribution to journal › Review article › peer-review

  • Bacteriology 100%
  • Tuberculosis 62%
  • DNA Probes 15%
  • Nucleic Acids 12%
  • Acids 9%
• 1993

  FREQUENCE ET GRAVITE ACTUELLES DE LA RESISTANCE DE MYCOBACTERIUM TUBERCULOSIS AUX ANTIBIOTIQUES

  Grosset, J., Jan 1 1993, In: Annales de l'Institut Pasteur/Actualites. 4, 3, p. 196-202 7 p.

  Research output: Contribution to journal › Review article › peer-review
  9 Scopus citations
• 1988

  Pharmacokinetics in drug screening

  Grosset, J. H., 1988, In: International Journal of Leprosy. 55, 4 SUPPL., p. 852-856 5 p.

  Research output: Contribution to journal › Review article › peer-review
  1 Scopus citations

• TUBERCULOSE ET GROSSESSE

  Translated title of the contribution: Tuberculosis and pregnancyDautzenberg, B. & Grosset, J., Jan 1 1988, In: Revue des maladies respiratoires. 5, 3, p. 279-283 5 p.

  Research output: Contribution to journal › Review article › peer-review
  16 Scopus citations
• 1987

  Etat actuel de la vaccination contre la lèpre.

  Translated title of the contribution: Present status of vaccination against leprosyGrosset, J. & Lecoeur, H., 1987, In: Acta leprologica. 5, 3, p. 231-239 9 p.

  Research output: Contribution to journal › Review article › peer-review
• 1980

  Bacteriologic basis of short-course chemotherapy for tuberculosis

  Grosset, J., 1980, In: Clinics in Chest Medicine. 1, 2, p. 231-241 11 p.

  Research output: Contribution to journal › Review article › peer-review

  • Pulmonary Tuberculosis 100%
  • Tuberculosis 78%
  • Drug Therapy 56%
  • Pharmaceutical Preparations 39%
  69 Scopus citations
• 1970

  La thiacétazone (Tb-1): données expérimentales et cliniques récentes.

  Translated title of the contribution: Thiacetazone (Tb-1): recent experimental and clinical dataGrosset, J. & Benhassine, M., Jan 1 1970, In: Bibliotheca tuberculosea. 26, p. 107-153 47 p.

  Research output: Contribution to journal › Review article › peer-review
  1 Scopus citations